These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33199676)

  • 21. Prevalence, Characteristics, and Outcome of Asthmatic Patients With Type 2 Diseases in Hospitalized Patients With COVID-19 in Madrid, Spain.
    Barroso B; Valverde-Monge M; Cañas Jose A; Rodrigo-Muñoz JM; Gonzalez-Cano B; Villalobos-Violan V; Betancor D; Gomez-Cardeñosa A; Vallejo-Chamorro G; Baptista-Serna L; Villalobos-Vilda C; Ortega-Martin L; Gómez-López A; Sanchez-Pernaute O; Romero-Bueno F; Rodriguez-Nieto MJ; Del Pozo V; Sastre J;
    J Investig Allergol Clin Immunol; 2020; 30(5):382-384. PubMed ID: 32554336
    [No Abstract]   [Full Text] [Related]  

  • 22. Serological tests for COVID-19.
    Bond K; Williams E; Howden BP; Williamson DA
    Med J Aust; 2020 Nov; 213(9):397-399.e1. PubMed ID: 32892381
    [No Abstract]   [Full Text] [Related]  

  • 23. Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22 - April 30, 2020.
    ; ; ;
    Indian J Med Res; 2020 May; 151(5):424-437. PubMed ID: 32611914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Universal SARS-CoV-2 testing on admission to the labor and delivery unit: Low prevalence among asymptomatic obstetric patients.
    Goldfarb IT; Diouf K; Barth WH; Robinson JN; Katz D; Gregory KE; Ciaranello A; Yawetz S; Shenoy ES; Klompas M
    Infect Control Hosp Epidemiol; 2020 Sep; 41(9):1095-1096. PubMed ID: 32456729
    [No Abstract]   [Full Text] [Related]  

  • 25. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
    García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM
    Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Web and phone-based COVID-19 syndromic surveillance in Canada: A cross-sectional study.
    Lapointe-Shaw L; Rader B; Astley CM; Hawkins JB; Bhatia D; Schatten WJ; Lee TC; Liu JJ; Ivers NM; Stall NM; Gournis E; Tuite AR; Fisman DN; Bogoch II; Brownstein JS
    PLoS One; 2020; 15(10):e0239886. PubMed ID: 33006990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial cluster of pneumonia and asymptomatic cases of COVID-19 in Taiwan.
    Chiu CH; Yeh KM; Su YS; Chiu SK; Lin JC; Yang YS
    J Formos Med Assoc; 2020 Oct; 119(10):1560-1561. PubMed ID: 32451217
    [No Abstract]   [Full Text] [Related]  

  • 28. Incidence of COVID-19 among ophthalmology professionals.
    Lacorzana J; Ortiz-Perez S; Rubio Prats M
    Med Clin (Barc); 2020 Sep; 155(5):225. PubMed ID: 32591177
    [No Abstract]   [Full Text] [Related]  

  • 29. Transmission Dynamics of COVID-19 Outbreaks Associated with Child Care Facilities - Salt Lake City, Utah, April-July 2020.
    Lopez AS; Hill M; Antezano J; Vilven D; Rutner T; Bogdanow L; Claflin C; Kracalik IT; Fields VL; Dunn A; Tate JE; Kirking HL; Kiphibane T; Risk I; Tran CH
    MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(37):1319-1323. PubMed ID: 32941418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic Stewardship: An Essential Element in a Rapidly Evolving COVID-19 Pandemic.
    Shah AS; Tande AJ; Challener DW; O'Horo JC; Binnicker MJ; Berbari EF
    Mayo Clin Proc; 2020 Sep; 95(9S):S17-S19. PubMed ID: 32807516
    [No Abstract]   [Full Text] [Related]  

  • 31. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
    Jing QL; Liu MJ; Zhang ZB; Fang LQ; Yuan J; Zhang AR; Dean NE; Luo L; Ma MM; Longini I; Kenah E; Lu Y; Ma Y; Jalali N; Yang ZC; Yang Y
    Lancet Infect Dis; 2020 Oct; 20(10):1141-1150. PubMed ID: 32562601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 diagnostic testing in Africa: needs and challenges.
    Adebisi YA; Oke GI; Ademola PS; Chinemelum IG; Ogunkola IO; Lucero-Prisno Iii DE
    Pan Afr Med J; 2020; 35(Suppl 2):4. PubMed ID: 32528615
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of Rapid Online Surveys to Assess People's Perceptions During Infectious Disease Outbreaks: A Cross-sectional Survey on COVID-19.
    Geldsetzer P
    J Med Internet Res; 2020 Apr; 22(4):e18790. PubMed ID: 32240094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State-March 2020.
    Rosenberg ES; Dufort EM; Blog DS; Hall EW; Hoefer D; Backenson BP; Muse AT; Kirkwood JN; St George K; Holtgrave DR; Hutton BJ; Zucker HA;
    Clin Infect Dis; 2020 Nov; 71(8):1953-1959. PubMed ID: 32382743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein - an observational study.
    Thiel SL; Weber MC; Risch L; Wohlwend N; Lung T; Hillmann D; Ritzler M; Risch M; Kohler P; Vernazza P; Kahlert CR; Fleisch F; Cusini A; Karajan TV; Copeland S; Paprotny M
    Swiss Med Wkly; 2020 Oct; 150():w20361. PubMed ID: 33105020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Universal screening for the SARS-CoV-2 virus on hospital admission in an area with low COVID-19 prevalence.
    Sastry SR; Pryor R; Raybould JE; Reznicek J; Cooper K; Patrick A; Knowlson S; Bailey P; Godbout E; Doll M; Stevens MP; Bearman G
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1231-1233. PubMed ID: 32698924
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic.
    Shi L; Lu ZA; Que JY; Huang XL; Liu L; Ran MS; Gong YM; Yuan K; Yan W; Sun YK; Shi J; Bao YP; Lu L
    JAMA Netw Open; 2020 Jul; 3(7):e2014053. PubMed ID: 32609353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China.
    Luo Y; Trevathan E; Qian Z; Li Y; Li J; Xiao W; Tu N; Zeng Z; Mo P; Xiong Y; Ye G
    Emerg Infect Dis; 2020 Aug; 26(8):1930-1933. PubMed ID: 32330112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.